Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.

Drugmaker struggled to adapt to very high demand and a market where celebrities are more influential than doctors ...

Novo Nordisk faces slowing demand, rising competition, and CEO transition. Learn about challenges impacting its growth and ...

The viral star discusses playing Glastonbury, breaking the conventional pop star mold and navigating her hurdle-ridden rise ...

The adoption of the new “clinical obesity” definition alters prevalence estimates of obesity in many parts of the world ...

A law requiring UK internet users to verify their age to access adult content has led to a huge surge in VPN downloads—and ...

A major Alzheimer’s disease medical group is recommending that specialists may use certain blood tests to help diagnose ...

In April, Danish drugmaker Novo Nordisk formed what was supposed to be a long-term collaboration to promote its weight-loss ...

The deaths of Chance, Carter, and Damian in The Young and the Restless were a shocking twist that left fans in disbelief.

Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer’s disease ...

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...